Importantly, previous studies have indicated the negative prognostic impacts of these mutations in myelofibrosis patients [9, 13, 14], and particularly, mutated TP53 has been identified as the worst subgroup [9, 14]. This evidence concerns the gene TP53 and myelofibrosis.